| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |